October 20, 2016 5:39 PM ET


Company Overview of MSI Methylation Sciences, Inc.

Company Overview

MSI Methylation Sciences, Inc., a pharmaceutical company, develops oral and small molecule therapies for adjunctive treatment of Major Depressive Disorder (MDD). It develops Strada, an orally administered therapy that improves the symptoms of depression in patients with MDD. The company was founded in 2007 and is based in Burnaby, Canada.

108-4475 Wayburne Drive

Burnaby, BC BC V5G 4X4


Founded in 2007





Key Executives for MSI Methylation Sciences, Inc.

Chief Technology Officer and Vice President
Chief Medical Officer
Compensation as of Fiscal Year 2016.

MSI Methylation Sciences, Inc. Key Developments

MSI Methylation Sciences Inc. Completes Recruitment of Phase 2 Trial for its Novel Treatment STRADA for Major Depressive Disorder

MSI Methylation Sciences Inc. announced the completion of patient recruitment for its HORIZON Phase 2 Study. HORIZON is designed to evaluate the efficacy and safety of MSI-195 (STRADA) in patients suffering from MDD who have had an inadequate response to current antidepressant therapy. The Horizon Study is being conducted exclusively in the US, under an IND, filed by MSI with the Food and Drug Administration, Center for Drug Evaluation and Research, Division of Psychiatry Products in 2013. The company expects results from the HORIZON Study in late 2015.

Similar Private Companies By Industry

Company Name Region
4everPets Ltd. Americas
9037136 Canada Inc. Americas
AAA Heidelberg Inc. Americas
Ab Biotech Inc. Americas
ABcann Medicinals Inc. Americas

Recent Private Companies Transactions

Private Placement
October 6, 2016

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MSI Methylation Sciences, Inc., please visit www.methylationsciences.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.